Ashish Goyal

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

ID3 deficiency alters chromatin accessibility at DSB sites and enhances vulnerability to HDAC inhibition.

ID3 deficiency alters chromatin accessibility at DSB sites and enhances vulnerability to HDAC inhibition.

Journal: International journal of cancer
Published: July 07, 2025

Prostate cancer cells converge to an inflammatory-like state upon metastatic dissemination.

Prostate cancer cells converge to an inflammatory-like state upon metastatic dissemination.

Journal: Nature communications
Published: April 25, 2025

DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia.

DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia.

Journal: Leukemia
Published: January 31, 2025

A tumor necrosis factor-α-responsive cryptic promoter drives overexpression of the human endogenous retrovirus ERVK-7.

A tumor necrosis factor-α-responsive cryptic promoter drives overexpression of the human endogenous retrovirus ERVK-7.

Journal: The Journal of biological chemistry
Published: December 27, 2024

Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.

Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.

Journal: Blood cancer discovery
Published: October 03, 2024

Deposition of onco-histone H3.3-G34W leads to DNA repair deficiency and activates cGAS/STING-mediated immune responses.

Deposition of onco-histone H3.3-G34W leads to DNA repair deficiency and activates cGAS/STING-mediated immune responses.

Journal: International journal of cancer
Published: November 23, 2023

Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijacking.

Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijacking.

Journal: Leukemia
Published: December 08, 2022

Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.

Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.

Journal: Molecular cancer
Published: November 21, 2022

DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts.

DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts.

Journal: Nature communications
Published: October 04, 2022

TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.

TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.

Journal: Haematologica
Published: June 16, 2022

ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibition.

ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibition.

Journal: Nucleic acids research
Published: July 19, 2021

Epigenetic Modulation of Radiation-Induced Diacylglycerol Kinase Alpha Expression Prevents Pro-Fibrotic Fibroblast Response.

Epigenetic Modulation of Radiation-Induced Diacylglycerol Kinase Alpha Expression Prevents Pro-Fibrotic Fibroblast Response.

Journal: Cancers
Published: March 08, 2021
Showing 1-12 of 22

Last Updated: 09/26/2026